Gallbladder disease : Cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation) have been reported with GLP-1 class agents
However, it must be noted that reduced plasma levels of amino acids during treatment with GCGR agonists may also reflect other mechanisms, such as weight loss, dietary changes, etc
If you want to eat, keep it tiny and bland If your body is asking for something solid, let it be simple
POSOLOGIA: Assumere 3 capsule al giorno, preferibilmente al mattino o prima dell'allenamento, con abbondante acqua
We are currently developing four investigational therapies for potential impact across several diseases: avexitide in post-bariatric hypoglycemia (PBH) and congenital hyperinsulinism (HI), AMX0035 in Wolfram syndrome, AMX0114 in amyotrophic lateral sclerosis (ALS), and AMX0318 in PBH and other rare diseases